+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
OHR Pharmaceutical Inc - logo

Ohr Pharmaceutical is a pharmaceutical company focused on the development of novel therapeutics for the treatment of ocular diseases. Its lead clinical program is its OHR-102 (Squalamine) eye drops, a small molecule anti-angiogenic drug that provides a non-invasive therapy to enhance vision. It could be used in the treatment of retinal diseases, including wet age related macular degeneration (AMD), retinal vein occlusion and diabetic retinopathy. OHR Pharmaceutical is headquartered in New York.

From
From
From
From
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • May 2018
  • 106 Pages
From
Retinal Degeneration - Pipeline Insight, 2018 - Product Thumbnail Image

Retinal Degeneration - Pipeline Insight, 2018

  • Drug Pipelines
  • May 2018
  • 217 Pages
From
From
From
Wet Age-related Macular Degeneration - Pipeline Insights, 2017 - Product Thumbnail Image

Wet Age-related Macular Degeneration - Pipeline Insights, 2017

  • Drug Pipelines
  • December 2017
  • 106 Pages
From
From
Fibroblast Growth Factor 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

Fibroblast Growth Factor 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 63 Pages
From
From
From
Loading Indicator
adroll